A weekly trade journal catering to the Indian chemical industry
backBack

calendar 25 February, 2025 17:22:17 IST

BASF India embarks on capacity expansion for microcellular polyurethanes

Article image

BASF India Ltd. has broken ground on a new plant to increase the production capacity of its Cellasto branded microcellular polyurethane (MCU) in Dahej, Gujarat. The plant, expected to be operational in the second half of 2026, features a new mould line in its first stage and will cater to the rapidly growing local market. 

It will be constructed with state-of-the-art technologies and automation systems to ensure that BASF’s high standards of safety and quality are upheld.  

BASF India established the first plant for MCU in Dahej in 2014, providing superior solutions that deliver noise, vibration, and harshness (NVH) reduction to the automotive industry. “Cellasto’s latest significant investment demonstrates its readiness to support the growth plans of various Original Equipment Manufacturers and its confidence in the Indian market,” a press release from BASF India said. 

“The new facility is part of our efforts to innovate the production process. The plant will flexibly expand production further if demand increases,” said Mr. Bjoern Kophstahl, Vice President, Global Business Management for Cellasto

“This new mould line will enhance our ability to deliver innovative NVH reduction solutions and continue to position us as a preferred partner for our automotive customers,” said Mr. Alexander Gerding, Managing Director, BASF India. 

Since 1961, Cellasto has established itself as a leading global partner to the automotive sector, co-developing various applications such as jounce bumpers, top mounts, coil spring isolators, and more. Additionally, Cellasto also offers material solutions for industrial and consumer applications.

article image
calender image

calender image 15 September, 2026 15:12:50 IST

The evolving global soda ash landscape and the paradox that is India’s market

The global soda ash industry is undergoing a structural transformation. Like in several petrochemical value chains,...
article image

calender image 17 September, 2026 18:19:14 IST

Chemical synthesis versus recombinant production of therapeutic peptides: Cost, quality and scale‑up considerations

Dr. Akshay Tiwari of Concorde Biotech compares chemical synthesis and recombinant production routes for therapeutic peptides. Chemical synthesis...

PRINT EDITION

View Past Issues

Search For

Exhibitions & Conferences

ChemExpo IndiaChemProTechChemLogistics India

Watch

KKBangEchemiICIF CHINA 2026GPCA - Reasearch InnovationGPCA Responsible CareGPCA ForumCPHI PMEC INDIA